undergoing cardioversion ~24 hours after TEE. At 6 months follow-up the presence of SR or AF was available in 276 patients. Baseline clinical variables and TEE parameters were compared between these Qroups. Results: At 6 months follow-up, 194 (70%) patients were in SR and 82 (30%) patients were in AF. Baseline clinical and TEE variables are displayed in Table 1 (' p<O.O5).
The hypothesis that mitral regurgitation (MR) may prevent stasis of blood in left atrium (LA) and thus prevent spontaneous echo contrast (SEC) and clot formation I" patients with severe mitral stenosis (MS) remains to be established.
Methods
One hundred patients with severe MS (area < 
Results
There was no significant difference in age, duration of symptoms, and mitral valve area in both the groups. Group I had significantly more atnal fibrillation, larger LA, and LAA area and significantly less SEC and LA clot compared to group II (Table) . dogs underwent l-hour of AF precipitated by pacing followed by a recovery period (control). VC (20 mglkg) was administrated and the control protocol was repeated. Transmitral (TMF) and left atrial appendage (LAA) flow velocities were acquired using transesophageal Doppler echocardiography at baseline, immediately post and every IO min after conversion. We normalized the velocities as a percentage of the baseline data and fitted them to the equation: y = p(l-exp((t,$)/TC)), where p is the plateau, b is x-axis intercept, t is time referenced to the termination of AF and TC is the time constant of recovery.
Results: Immediately after cessation of AF, peak atrial TMF velocity (A) reduced to 61 * 17 % of baseline in control, 69 f 10 % with VC. The peak emptying LAA flow velocity reduced to 25 * 7 % of baseline in control, 31 * 9 % with VC. Background:ln pabents with cryptogenlc embolic neurologlc events, paradoxical emboli through intra atrial shunts can be an important source. While this can be assessed by contrast transthoracic echocardlography (TTE) and confirmed by transesophageal echo (TEE), the additional value of contrast transesophageal echo is unclear. Method:We searched our database over the last IO years and identified patients where both a contrast transthoracic and transesophageal echo's were performed as part of the evaluation of a cryptogenic neurologic event (CVA,TIA, source of embolus. The relative ability of these methods to detect intracardiac shunting was compared using a clearly positive study by either or both methods as the gold standards. Results: Of a total of 102,818 echoes performed over the IO years, 749 patients were identified in which transesophageal echo was performed for this indication.Of these, 244 had a transthoracic echo with saline contrast (SC) within 1 month of their transesophageal echo.
-iTE Conclusions: Tranthoracic echocardiography with saline contrast can accurately assess the presence of significant intracardiac shunt in patients with cryptogenic neurologic events. The TEE echo has sliohtlv better sensitivitv and soecificitv but onlv in small number of cases where salinecdntrast bubbles were s&II in r&ber or appeared late did TEE orovide increased sensitivitv. Thus for sole identification of intracardiac shuntina. there is limited value of the addition of a TEE to a saline contrast
